dendreon corp (DNDN:NASDAQ GS)

Executive Profile*

Background*

Mr. Richard B. Brewer, Dick served as Chief Executive Officer and President of Myrexis, Inc from May 11, 2012 to August 15, 2012. Mr. Brewer served as the Chief Executive Officer and President of Arca Biopharma, Inc. (formerly ARCA Discovery, Inc.) from November 2006 to July 10, 2009. He served as Founding\Managing Partner of Crest Asset Management since January 2003, where he provided guidance to and invested in biotechnology opportunities. Mr. Brewer joined ARCA in ... November 2006. He had 30 years of biopharmaceutical industry experience, developing and commercializing drugs for major unmet medical needs, particularly in heart disease. He served as President and Chief Executive Officer of Scios Inc., a subsidiary of Johnson & Johnson from September 1998 to February 2004, where he led Scios through the successful approval and launch of Natrecor(R) (nesiritide), the first new drug for acute heart failure in more than a decade, and guided Scios through its $2.4 billion merger with Johnson and Johnson. From February 1996 to June 1998, he served as an Executive Vice President of Operations and Chief Operating Officer of Heartport, Inc. and was responsible for overall management for the establishment and development of Genentech's European operations and, in addition, spearheaded all global product launches prior to 1995. He served as Head of Global Product Launches, where Mr. Brewer was responsible for growing the franchise for Activase(R), Genentech's blockbuster heart attack drug. From 1984 to 1995, he served in various capacities for Genentech Europe Ltd., Genentech Canada, Inc. and Genentech, Inc., where he served as Senior Vice President of U.S. Sales and Marketing and Senior Vice President of Genentech Europe and Canada and Genentech Inc. He served at Nuvelo Inc. He served as an Executive Chairman and Director of Nile Therapeutics Inc., since July 21, 2010. He served as Chairman of ARCA biopharma, Inc. since July 10, 2009. Mr. Brewer served as Chairman of Dendreon Corp., from June 16, 2004 to January 31 2012. From 1994 to 1995, he served as the Chairman of the American Heart Association Pharmaceutical Roundtable. He served as a Director of Intersect ENT Inc. He served as a Director of Dendreon Corp. from February 23, 2004, to January 31, 2012 , SRI International, Inc. since January 2006. Mr. Brewer served as an Executive Director of Arca Biopharma, Inc. since January 2009 and Scios Inc. since September 1998. He served as Director of Myrexis, Inc from May 11, 2012 to August 15, 2012. He served as a Director of Sinexus, Inc., Northwestern University and Agensys, Inc. He served as an Advisory Board Member for the Center for Accelerating Medical Solutions (CAMS). He served as Director of Corus Pharma Inc. since April 2004. Mr. Brewer served as a Director of Anesiva, Inc., until March 20, 2006. He served as a Director of Corgentech Inc., from April 19, 2004 to March 2006 and Arginox Pharmaceuticals, Inc. He served as an Advisory Board Member of the Kellogg Graduate School of Management and the Center for Biotechnology at Northwestern University. From 1993 to 1994, he served as a Member of the American Heart Association Corporate Roundtable. Mr. Brewer was an active Patient Advocate. Mr. Brewer had a B.S from Virginia Polytechnic Institute and State University. He had an M.B.A from Northwestern University. Mr. Brewer passed away in August 2012.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
DNDN:US	$3.95 USD	-0.01

COMPETITOR COMPENSATION